Sign in
4

Changes in Ownership

PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001493152-21-015023

Options or other derivatives

  • Director acquired 0 shares (grant or award)
  • Director acquired 0 shares (option exercise)
  • Director acquired 478,926 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Pershing Edward · Director

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2021-06-17 Grant or award : show line 1 in the form 8% Secured Convertible Promissory Notes due 2021 +0 D
2021-06-20 Exercise or conversion : show line 2 in the form 8% Secured Convertible Promissory Notes due 2021 −0 0 D
2021-06-20 Exercise or conversion : show line 3 in the form Series D-1 Convertible Preferred Stock +478,926 478,926 D
Loading xslF345X03/ownership.xml…